---
schema_version: "secwatch.filing_event.v1"
accession: "0001628945-24-000005"
form_type: "8-K"
ticker: null
cik: "0001628945"
company_name: "Cue Health Inc."
filed_at: "2024-01-05T23:59:59+00:00"
generated_at: "2026-06-07T03:08:05.685672+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cue Health lays off 13% of workforce; FDA rejects priority review for Flu+COVID test

## Summary
- Workforce reduction of 94 employees (~13% global workforce) as part of new cost reduction plan.
- Estimated restructuring charges of $2.1M-$2.8M cash plus $0.1M non-cash stock-based.
- FDA on Dec 28, 2023 declined to issue EUA for Flu A/B + COVID-19 molecular test; review not a priority.
- FDA cites significant issues, COVID-19 testing landscape, and resource constraints; future EUA submission not precluded.

## SEC filing metadata
- accession: 0001628945-24-000005
- form_type: 8-K
- cik: 0001628945
- company_name: Cue Health Inc.
- filed_at: 2024-01-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.05, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000005/0001628945-24-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000005/hlth-20240104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628945-24-000005
- JSON: https://secwatch.observer/filing/0001628945-24-000005.json
- Plain text: https://secwatch.observer/filing/0001628945-24-000005.txt

## Key facts
- Restructurings & Charges
  Cue Health Inc. announced a restructuring with charges of approximately $2.1 million to $2.8 million (94 employees).
  - Type: restructuring
  - Charge: approximately $2.1 million to $2.8 million
  - Headcount: 94 employees
  source text: In connection with the CRP, the Company estimates that it will record an aggregate restructuring charge related to one-time termination benefits in the range of approximately $2.1 million to $2.8 million. The substantial majority of these charges will result in cash expenditures. Cash expenditures in connection with the CRP consist of payments for salary,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000005/0001628945-24-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.